+ Follow Sanofi Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2394236
[Title] => Sanofi pursues sale of painkiller after political controversy
[Summary] => Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.
[DatePublished] => 2024-10-21 19:09:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2024/10/21/sanofi_2024-10-21_19-09-12143_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 2277458
[Title] => PharmAcademy: Guiding pharmacists to become trusted, indispensable community healthcare providers
[Summary] => PharmAcademy enhances pharmacists’ knowledge and skills with Continuing Professional Development (CPD), Digital Learning Campaigns, and soft skills and business acumen learning modules at zero cost.
[DatePublished] => 2023-06-30 12:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Supplements
[SectionUrl] => supplements
[URL] => https://media.philstar.com/photos/2023/06/29/lead-photo-pharmacademy_2023-06-29_12-23-3197_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 2108986
[Title] => France's Sanofi to invest 2 billion euros in mRNA vaccines
[Summary] => Sanofi, which was left trailing in the race to break out a Covid vaccine in 2020, said it would invest 400 million euros a year between now and 2025 to develop at least six vaccine candidates using messenger ribonucleic acid (mRNA).
[DatePublished] => 2021-06-29 18:35:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1807170
[AuthorName] => Marie-Morgane Le Moel
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2021/06/29/sanofi-covid-vaccine_2021-06-29_18-36-58_thumbnail.jpg
)
[3] => Array
(
[ArticleID] => 2079833
[Title] => Sanofi, AC Health deal seen to benefit patients with non-communicable diseases
[Summary] => The partnership will combine Sanofi's treatment solutions and AC Health's network.
[DatePublished] => 2021-02-23 18:03:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1806532
[AuthorName] => Ratziel San Juan
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2021/02/23/hospital_2021-02-23_12-36-09_thumbnail.jpg
)
[4] => Array
(
[ArticleID] => 2039346
[Title] => Sanofi halts testing for COVID-19 drug after failing Phase 3 trials
[Summary] => The Philippines is looking to become among the first takers of a COVID-19 vaccine, allotting P2.5 billion for the purchase of still unavailable immunization next year.
[DatePublished] => 2020-09-01 15:09:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1106780
[AuthorName] => Agence France-Presse
[SectionName] => Business
[SectionUrl] => business
[URL] => https://media.philstar.com/photos/2020/08/28/s_2020-08-28_21-58-53719_thumbnail.jpg
)
[5] => Array
(
[ArticleID] => 1961532
[Title] => Sanofi recalls popular heartburn drug in US and Canada
[Summary] => French pharmaceutical giant Sanofi on Friday said it was recalling over-the-counter heartburn medication Zantac in the United States and Canada after a possible carcinogen was detected.
[DatePublished] => 2019-10-19 11:40:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2019/10/19/medicine_2019-10-19_11-42-04625_thumbnail.jpg
)
[6] => Array
(
[ArticleID] => 1944954
[Title] => 807 na ang namatay sa dengue sa Pilipinas mula Enero
[Summary] => Inatasan na ng Department of Health ang mga regional directors nito na i-"localize" ang kanilang pamamaraan upang masugpo ang epidemyang nararanasan ng bansa.
[DatePublished] => 2019-08-20 12:23:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Bansa
[SectionUrl] => bansa
[URL] => https://media.philstar.com/photos/2019/08/20/gen5-dengue-fogging-boysantos2019-08-1222-45-25_2019-08-20_11-56-57273_thumbnail.jpg
)
[7] => Array
(
[ArticleID] => 1944889
[Title] => Dengue cases hit 188,000; 807 dead
[Summary] => As the number of dengue cases hit more than 188,000 this month, the Department of Health (DOH) has asked its regional directors to localize their approach to curbing the epidemic being experienced by the country.
[DatePublished] => 2019-08-20 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2019/08/19/gen3-duque-iii-dengue_2019-08-19_22-49-55129_thumbnail.jpg
)
[8] => Array
(
[ArticleID] => 1943529
[Title] => Sanofi hoping for restoration of Dengvaxia registration
[Summary] => Pharmaceutical firm Sanofi Pasteur is hopeful that the Food and Drug Administration (FDA) will restore the registration of Dengvaxia, the company’s dengue vaccine, saying it can prevent future epidemics.
[DatePublished] => 2019-08-15 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2019/08/14/gen11-dengvaxia-vaccine-miguel-de-guzman_2019-08-14_22-54-36802_thumbnail.jpg
)
[9] => Array
(
[ArticleID] => 1927534
[Title] => Sanofi turns to Google in search for better treatments
[Summary] => French pharmaceutical firm Sanofi said Tuesday it is  partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to find better treatments.
[DatePublished] => 2019-06-18 15:38:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2019/06/18/vaccine_2019-06-18_15-38-46518_thumbnail.jpg
)
)
)
Sanofi
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2394236
[Title] => Sanofi pursues sale of painkiller after political controversy
[Summary] => Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.
[DatePublished] => 2024-10-21 19:09:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2024/10/21/sanofi_2024-10-21_19-09-12143_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 2277458
[Title] => PharmAcademy: Guiding pharmacists to become trusted, indispensable community healthcare providers
[Summary] => PharmAcademy enhances pharmacists’ knowledge and skills with Continuing Professional Development (CPD), Digital Learning Campaigns, and soft skills and business acumen learning modules at zero cost.
[DatePublished] => 2023-06-30 12:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Supplements
[SectionUrl] => supplements
[URL] => https://media.philstar.com/photos/2023/06/29/lead-photo-pharmacademy_2023-06-29_12-23-3197_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 2108986
[Title] => France's Sanofi to invest 2 billion euros in mRNA vaccines
[Summary] => Sanofi, which was left trailing in the race to break out a Covid vaccine in 2020, said it would invest 400 million euros a year between now and 2025 to develop at least six vaccine candidates using messenger ribonucleic acid (mRNA).
[DatePublished] => 2021-06-29 18:35:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1807170
[AuthorName] => Marie-Morgane Le Moel
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2021/06/29/sanofi-covid-vaccine_2021-06-29_18-36-58_thumbnail.jpg
)
[3] => Array
(
[ArticleID] => 2079833
[Title] => Sanofi, AC Health deal seen to benefit patients with non-communicable diseases
[Summary] => The partnership will combine Sanofi's treatment solutions and AC Health's network.
[DatePublished] => 2021-02-23 18:03:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1806532
[AuthorName] => Ratziel San Juan
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2021/02/23/hospital_2021-02-23_12-36-09_thumbnail.jpg
)
[4] => Array
(
[ArticleID] => 2039346
[Title] => Sanofi halts testing for COVID-19 drug after failing Phase 3 trials
[Summary] => The Philippines is looking to become among the first takers of a COVID-19 vaccine, allotting P2.5 billion for the purchase of still unavailable immunization next year.
[DatePublished] => 2020-09-01 15:09:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1106780
[AuthorName] => Agence France-Presse
[SectionName] => Business
[SectionUrl] => business
[URL] => https://media.philstar.com/photos/2020/08/28/s_2020-08-28_21-58-53719_thumbnail.jpg
)
[5] => Array
(
[ArticleID] => 1961532
[Title] => Sanofi recalls popular heartburn drug in US and Canada
[Summary] => French pharmaceutical giant Sanofi on Friday said it was recalling over-the-counter heartburn medication Zantac in the United States and Canada after a possible carcinogen was detected.
[DatePublished] => 2019-10-19 11:40:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2019/10/19/medicine_2019-10-19_11-42-04625_thumbnail.jpg
)
[6] => Array
(
[ArticleID] => 1944954
[Title] => 807 na ang namatay sa dengue sa Pilipinas mula Enero
[Summary] => Inatasan na ng Department of Health ang mga regional directors nito na i-"localize" ang kanilang pamamaraan upang masugpo ang epidemyang nararanasan ng bansa.
[DatePublished] => 2019-08-20 12:23:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Bansa
[SectionUrl] => bansa
[URL] => https://media.philstar.com/photos/2019/08/20/gen5-dengue-fogging-boysantos2019-08-1222-45-25_2019-08-20_11-56-57273_thumbnail.jpg
)
[7] => Array
(
[ArticleID] => 1944889
[Title] => Dengue cases hit 188,000; 807 dead
[Summary] => As the number of dengue cases hit more than 188,000 this month, the Department of Health (DOH) has asked its regional directors to localize their approach to curbing the epidemic being experienced by the country.
[DatePublished] => 2019-08-20 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2019/08/19/gen3-duque-iii-dengue_2019-08-19_22-49-55129_thumbnail.jpg
)
[8] => Array
(
[ArticleID] => 1943529
[Title] => Sanofi hoping for restoration of Dengvaxia registration
[Summary] => Pharmaceutical firm Sanofi Pasteur is hopeful that the Food and Drug Administration (FDA) will restore the registration of Dengvaxia, the company’s dengue vaccine, saying it can prevent future epidemics.
[DatePublished] => 2019-08-15 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2019/08/14/gen11-dengvaxia-vaccine-miguel-de-guzman_2019-08-14_22-54-36802_thumbnail.jpg
)
[9] => Array
(
[ArticleID] => 1927534
[Title] => Sanofi turns to Google in search for better treatments
[Summary] => French pharmaceutical firm Sanofi said Tuesday it is  partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to find better treatments.
[DatePublished] => 2019-06-18 15:38:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2019/06/18/vaccine_2019-06-18_15-38-46518_thumbnail.jpg
)
)
)
abtest
October 21, 2024 - 7:09pm
October 19, 2019 - 11:40am
August 20, 2019 - 12:23pm
